BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SenzaGen
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20181204T150000
DTEND;TZID=Europe/Stockholm:20181204T160000
DTSTAMP:20181106T104722Z
CREATED:20181105T160230Z
LAST-MODIFIED:20181106T104722Z
UID:18231-1543935600-1543939200@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasions\, this one targeted for the EUROPEAN time zone \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\n\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs. \n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™\nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy. \nDon’t miss the opportunity to learn more from our researchers. Welcome to join! \nREGISTER HERE
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181205T130000
DTEND;TZID=America/New_York:20181205T140000
DTSTAMP:20181106T104647Z
CREATED:20181105T160248Z
LAST-MODIFIED:20181106T104647Z
UID:18240-1544014800-1544018400@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasion. This one targeted forthe US audience at 13:00 EST  (19:00 CET) \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs.\n\n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™ \nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy \n\nDon’t miss the opportunity to learn more from our researchers. Welocome to join! \nREGISTER HERE \n  \n 
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen-2/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181213
DTSTAMP:20181029T172652Z
CREATED:20181029T111645Z
LAST-MODIFIED:20181029T172652Z
UID:18070-1544400000-1544659199@senzagen.com
SUMMARY:The Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018
DESCRIPTION:SenzaGen is participating at \nThe Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018\nWHAT’S IN A NAM ?  (NOVEL APPROACH METHODOLOGIES). \nBENEFITS\, LIMITATIONS\, TRANSLATION\, COMMUNICATION. \n| DECEMBER 10 TO 12\, 2018 |\n| VENUE:  COURTYARD BY MARRIOTT – TORONTO | \nThe Society of Toxicology of Canada Inc. is a non-profit association whose objectives are to promote the acquisition\, facilitate the dissemination\, and encourage the utilization of knowledge in the science of toxicology. \nThe STC supports continuing education and excellence in research through its Annual Symposium\, which provides a venue for members and international experts to present the latest advances in experimental and regulatory toxicology. \nThe Society recognizes the universality of science and adheres to principles which affirm membership and free circulation of bona fide scientists in a non-discriminatory fashion.
URL:https://senzagen.com/event/the-society-of-toxicology-of-canada-50th-annual-symposium-winter-2018/
LOCATION:COURTYARD BY MARRIOTT – TORONTO DOWNTOWN
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/toronto-city.jpg
END:VEVENT
END:VCALENDAR